Transcription and Translation in Health and Disease
Editat de Manoj Garg, Gautam Sethi, Amit Kumar Pandeyen Limba Engleză Paperback – 2 feb 2023
It provides a structured and detailed overview of the various regulators underlying molecular processes and their impact on health and disease, equipping readers with the necessary knowledge for further investigation in the areas of treatment and therapeutic intervention.
- Discusses the role played by transcription and translational regulation in various diseases, including cancer, diabetes, cardiovascular disease and neurological disease
- Considers a range of post-transcriptional regulators, including RNA-binding proteins, non-coding RNAs, epigenetic modifiers, alternative splicing and telomerase-binding proteins
- Covers the topic from fundamental knowledge to the latest developments in clinical application
- Includes a section dedicated to therapeutic applications
Preț: 746.32 lei
Preț vechi: 972.75 lei
-23% Nou
Puncte Express: 1119
Preț estimativ în valută:
142.83€ • 148.72$ • 120.71£
142.83€ • 148.72$ • 120.71£
Carte tipărită la comandă
Livrare economică 28 februarie-14 martie
Livrare express 30 ianuarie-05 februarie pentru 96.76 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323995214
ISBN-10: 0323995217
Pagini: 416
Dimensiuni: 191 x 235 x 25 mm
Greutate: 0.86 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0323995217
Pagini: 416
Dimensiuni: 191 x 235 x 25 mm
Greutate: 0.86 kg
Editura: ELSEVIER SCIENCE
Public țintă
Researchers in molecular biology, biochemistry, cell biology, genetics, microbiology, biotechnology, and pharma / therapeuticsUndergraduate and postgraduate students in related fields
Cuprins
Section I: Introduction
1. Current perspectives on transcription and translational regulators in Health and diseases
2. Role of alternative splicing in health and diseases
Section II: Transcriptional and translational regulators in cancer
3. Transcriptional regulation in cancer progression
4. Role of transcriptional and post-transcriptional regulation of sphingolipid genes in molecular heterogeneity of breast cancer
5. Who dictates and when: Genetic and epigenetic dictatorships in breast cancer response and resistance to therapy
6. CRISPR/Cas9 mediated regulation in cancer
7. Biomarkers for Diagnosis, Prognosis, Treatment of Gastro-Intestinal cancer
8. Regulation of post-transcriptional events by RNA-binding proteins
9. The language of post-translational modifications in cancers and other diseases
10. Ubiquitin proteasome system-mediated regulation of protein function and stability
11. Post-transcriptional regulations in epithelial-tomesenchymal transition and endothelial-to-mesenchymal transitions
Section III: Transcriptional and translation regulators of other diseases
12. Noncoding RNAs in Diabetes
13. MicroRNAs as epigenetic regulators for gut microbiome
14. Cross talk between miRNAs and epigenetics during braindevelopment and neurological diseases
15. The role of non-coding RNAs in rheumatoid arthritis
16. Role of miRNA in autoimmune and inflammatory skin diseases
17. Current Advances in Cancer Prevention and Treatment by Natural Products
18. Therapeutic inhibition of pro-inflammatory cytokins by phytochemicals in osteoarthritis
19. Redox Signaling and Cardiovascular Disease: New Paradigms and discoveries
Section IV: Therapeutics
20. Modulation of epigenetic enzymes by natural agents
21. Inhibitors targeting epigenetic modifications in cancer
22. Drug rechanneling a new paradigm for cancer treatment
1. Current perspectives on transcription and translational regulators in Health and diseases
2. Role of alternative splicing in health and diseases
Section II: Transcriptional and translational regulators in cancer
3. Transcriptional regulation in cancer progression
4. Role of transcriptional and post-transcriptional regulation of sphingolipid genes in molecular heterogeneity of breast cancer
5. Who dictates and when: Genetic and epigenetic dictatorships in breast cancer response and resistance to therapy
6. CRISPR/Cas9 mediated regulation in cancer
7. Biomarkers for Diagnosis, Prognosis, Treatment of Gastro-Intestinal cancer
8. Regulation of post-transcriptional events by RNA-binding proteins
9. The language of post-translational modifications in cancers and other diseases
10. Ubiquitin proteasome system-mediated regulation of protein function and stability
11. Post-transcriptional regulations in epithelial-tomesenchymal transition and endothelial-to-mesenchymal transitions
Section III: Transcriptional and translation regulators of other diseases
12. Noncoding RNAs in Diabetes
13. MicroRNAs as epigenetic regulators for gut microbiome
14. Cross talk between miRNAs and epigenetics during braindevelopment and neurological diseases
15. The role of non-coding RNAs in rheumatoid arthritis
16. Role of miRNA in autoimmune and inflammatory skin diseases
17. Current Advances in Cancer Prevention and Treatment by Natural Products
18. Therapeutic inhibition of pro-inflammatory cytokins by phytochemicals in osteoarthritis
19. Redox Signaling and Cardiovascular Disease: New Paradigms and discoveries
Section IV: Therapeutics
20. Modulation of epigenetic enzymes by natural agents
21. Inhibitors targeting epigenetic modifications in cancer
22. Drug rechanneling a new paradigm for cancer treatment
Recenzii
"... to uncover the details concerning how gene expression is controlled,… this book consists of 19 independently authored chapters designed to "bring our vast knowledge gene expression regulation under a single canopy." Given the near infinite dimensions of the subject at hand,… the goal of this book is to produce a relatively compact and up-to-date overview of transcriptional and translational gene regulatory mechanisms, [and] it is important to consider whether the wealth of knowledge on this topic is too vast to distill into a single volume.” --©Doody’s Review Service, 2023, Peter J. Kennelly, PhD (Virginia Tech)